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Objectives This study evaluated the association of long- and short-term air pollutant exposures with flow-mediated dilation
(FMD) and baseline arterial diameter (BAD) of the brachial artery using ultrasound in a large multicity cohort.
Background Exposures to ambient air pollution, especially long-term exposure to particulate matter 2.5 m in aerodynamic
diameter (PM2.5), are linked with cardiovascular mortality. Short-term exposure to PM2.5 has been associated
with decreased FMD and vasoconstriction, suggesting that adverse effects of PM2.5 may involve endothelial dys-
function. However, long-term effects of PM2.5 on endothelial dysfunction have not been investigated.
Methods FMD and BAD were measured by brachial artery ultrasound at the initial examination of the Multi-Ethnic Study
of Atherosclerosis. Long-term PM2.5 concentrations were estimated for the year 2000 at each participant’s resi-
dence (n  3,040) using a spatio-temporal model informed by cohort-specific monitoring. Short-term PM2.5 con-
centrations were based on daily central-site monitoring in each of the 6 cities.
Results An interquartile increase in long-term PM2.5 concentration (3 g/m3) was associated with a 0.3% decrease in
FMD (95% confidence interval [CI] of difference: 0.6 to 0.03; p  0.03), adjusting for demographic charac-
teristics, traditional risk factors, sonographers, and 1/BAD. Women, nonsmokers, younger participants, and
those with hypertension seemed to show a greater association of PM2.5 with FMD. FMD was not significantly
associated with short-term variation in PM2.5 (0.1% per 12 g/m
3 daily increase [95% CI: 0.2 to 0.04] on
the day before examination).
Conclusions Long-term PM2.5 exposure was significantly associated with decreased endothelial function according to brachial
ultrasound results. These findings may elucidate an important pathway linking air pollution and cardiovascular
mortality. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487) (J Am Coll Cardiol 2012;60:2158–66)
© 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.973Air pollution is a complex mixture of particulate matter,
volatile organic compounds, and gaseous pollutants such as
oxides of nitrogen. Epidemiological analyses have demon-
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November 20/27, 2012:2158–66 Endothelial Dysfunction and Air Pollutioncular morbidity and mortality (1,2). It is postulated that this
adverse cardiovascular effect is related to systemic inflam-
mation, oxidative stress, or autonomic nervous system
imbalance effects in the artery wall (3). Hence, one of the
intermediate steps by which PM2.5 exposure increases
cardiovascular morbidity and mortality may be via func-
tional changes in the endothelium–smooth muscle
complex.
See page 2167
Previous studies have shown associations between short-
term exposure to PM2.5 and nitric oxide (NO)-mediated
ndothelial dysfunction measured by using forearm pleth-
smography (4) or flow-mediated dilation (FMD) using
rachial ultrasound (5,6). In a study of healthy volunteers
ituated for 2 h at different urban bus stops, a 30-g/m3
increase in PM2.5 exposure corresponded to a 0.5% reduc-
ion in FMD (7). In contrast, other experimental studies
ave shown associations with vasoconstriction measured as a
ecrease in baseline arterial diameter (BAD) but not FMD
8,9). These studies provide different conclusions: PM2.5 ex-
posure may primarily affect NO-mediated endothelial dysfunc-
tion or it may alter elaboration of vasoconstrictors.
Observations from short-term exposure studies provide
only limited insight into effects of pollutants and mecha-
nisms. Are the vascular responses transient or do lasting
effects accrue after long-term exposure? We hypothesized
that repeated short-term insults to the vasculature result in
persistent endothelial dysfunction related to long-term ex-
posures. To test this hypothesis, we investigated the rela-
tionship between PM2.5 exposures and changes in the
rachial artery in the MESA (Multi-Ethnic Study of
therosclerosis) cohort. Leveraging the detailed exposure
ssignment of the MESA Air Pollution (MESA Air) study,
e examined whether long- and short-term exposure to
M2.5 is associated with decreased FMD and/or decreased
BAD in this cohort.
Methods
Study design. MESA is a prospective study designed to
investigate the prevalence and progression of subclinical
atherosclerosis in participants aged 45 to 84 years who were
free of clinical cardiovascular disease at the time of enroll-
ment (10). The study includes 6,814 participants of white,
African American, Hispanic, and Chinese descent from 6 US
communities. The institutional review boards of each study site
approved this study, and all participants gave written informed
consent. Demographic characteristics, medical history, anthro-
pometry, laboratory data, and brachial ultrasound measure-
ments for the current analysis were taken at the first examina-
tion (July 2000 to August 2002). For this study, we included all
participants with reliable brachial ultrasound measurements for
whom complete covariate information and exposure estimates
were available (N  3,040). sVascular outcomes. The bra-
chial examination procedure, in-
clusion and exclusion criteria,
and reproducibility measures are
reported in detail elsewhere (11).
Briefly, participants were exam-
ined in the supine position after
at least a 6-h fast and 15 min of
rest. A standard blood pressure
cuff was positioned around the
right arm, 2 inches below the
antecubital fossa, and the bra-
chial artery was imaged 5 to 9 cm
above the antecubital fossa by
using a linear-array multifre-
quency transducer operating at 9
MHz and the LOGIQ 700 ul-
trasound (General Electric Logic
700 Device General Electric
Medical Systems, Waukesha,
Wisconsin). After the baseline images were obtained contin-
uously for 30 s to obtain the BAD, the cuff was inflated to 50
mm Hg for 5 min above the participant’s systolic blood
pressure (SBP). After cuff deflation, the maximum arterial
diameter (MAD) was measured. Image analysis was performed
at the Wake Forest University Cardiology Image Processing
Laboratory by using a previously validated semiautomated
system that uses media-adventitial interfaces (12).
FMD% was computed as :
MAD – BAD 100
BAD
BAD (in millimeters) and FMD% were our main out-
come measures and are based on recent guidelines (13). The
number of sonographers acquiring images varied between the
cities, ranging from 1 in St. Paul to 9 in Chicago. Each
sonographer underwent central training, performed a super-
vised examination, and acquired at least 5 examinations accept-
able to the core laboratory before certification. Intrareader
reproducibility for BAD and FMD, evaluated by comparing an
original and a blinded quality control reread of ultrasounds
from 40 participants, was reported previously (11).
Exposure assessment. LONG-TERM PM2.5 EXPOSURE
SSESSMENT. Estimates of long-term average ambient
PM2.5 concentrations were computed for each participant
y using a hierarchical spatio-temporal model fit with an
stimation procedure described elsewhere (14–16). Moni-
oring data came from the U.S. Environmental Protection
gency’s Air Quality System regulatory monitoring stations
upplemented by several fixed-site monitoring stations in
ach MESA community and home-monitoring at 10% of
ESA participant homes, in campaigns specifically de-
loyed for the MESA Air cohort (17). The hierarchical
odel decomposed the space-time field of concentrations into
components: 1) spatially varying long-term averages; 2)
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
BAD  baseline arterial
diameter
BMI  body mass index
FMD  flow-mediated
dilation
IQR  interquartile range
MAD  maximum arterial
diameter
NO  nitric oxide
PM2.5  particulate matter
<2.5 m in aerodynamic
diameter
SBP  systolic blood
pressurepatially varying seasonal and long-term trends; and 3) spatially
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Endothelial Dysfunction and Air Pollution November 20/27, 2012:2158–66correlated but temporally independent residuals. The spatially
varying long-term averages and seasonal trends were modeled
by using land-use regression and spatial smoothing of residuals
using universal kriging. A large suite of spatial covariates such
as proximity to major roadways and local land-use were used as
predictors in the universal kriging models, after dimension
reduction by partial least-squares. The spatially correlated but
temporally independent residuals were predicted by using
ordinary kriging. These components were combined to predict
concentrations at each subject’s home location for every 2-week
period starting in January 1999. An average of exposures for
the calendar year 2000 were used for this analysis. We used
ArcGIS 9.1 software (Esri, Redlands, California); Dynamap/
2000 street network and geocoding database (TeleAtlas, Bos-
ton, Massachusetts) were used to determine participants’ resi-
dential addresses.
SHORT-TERM PM2.5 EXPOSURE ASSESSMENT. We assessed
each participant’s short-term exposure to PM2.5 concentrations
on the day of the examination (day 0), 1 day prior, 2 days prior,
and the average of days 0 to 2. Daily average PM2.5 concen-
trations were derived from an air quality system central-site
monitoring station with complete daily average information
available for the study city during the examination period (14).
COVARIATES. A number of covariates were considered in the
multivariate analysis. These included age, gender, ethnicity,
education, income, body surface area, smoking status, alcohol
consumption, dietary fat intake, emotional distress derived
from a standardized anxiety scale, and physical activity. We
also adjusted for waist to hip ratio, blood glucose, SBP,
diastolic blood pressure, high-density lipoprotein, total choles-
terol, triglycerides, homocysteine, fibrinogen, and C-reactive
protein. We also adjusted for specific medications, including
anti-inflammatory agents, antihypertensives, lipid-lowering
medications, and antioxidants (vitamin C).
Statistical analysis. Using Stata version 10.1 (Stata Corp.,
College Station, Texas) and SAS version 9.1.3 (SAS Insti-
tute, Inc., Cary, North Carolina), summary statistics were
calculated and analyses performed. We tested for differences
between the full cohort and those with complete data by
using a t test for continuous covariates and chi-square test
for the categorical covariates. Linear regression modeling
was performed to examine associations between PM2.5 esti-
mates and the main vascular outcomes. Because the sonogra-
phers vary by study location and can influence these outcomes,
the analyses were adjusted by using an indicator variable for
sonographer. Each sonographer worked in only 1 study site; in
effect, our analysis controls for study site as well.
The ratio outcome (FMD%) requires careful statistical
consideration because the denominator (BAD) may itself be
associated with the exposure. In our primary approach, we
included 1/BAD as a covariate in regression models to obtain
unbiased effect estimates and to increase precision (18). We
also evaluated the FMD% outcome without adjusting for
1/BAD and have referred to it as “FMD% without adjustment
for 1/BAD.” In a sensitivity analysis, we also used simple extent tof dilation (“FMDmm”), calculated as MAD-BAD, as re-
ported in the Framingham Heart Study (13,19). Results are
reported per interquartile range (IQR) change in PM2.5.
The role of all the aforementioned covariates, including
secondhand smoke exposures, family history of myocardial
infarction, serum cotinine, and forced expiratory volume in
1 s, were examined. However, these were not included in
the final model due to a large amount of missing data.
To control for temporal and meteorological confounding
in short-term analyses, B-splines were used for city-specific
trends in calendar time (12 df/year), temperature (6 df), and
relative humidity (6 df) and included a city-specific day of
the week indicator. In addition, long- and short-term
exposures were evaluated jointly, including the temporal and
meteorological confounders.
In another sensitivity analysis, the final model was not
controlled for sonographer (or city) to determine between-
city estimates. In separate city-specific analyses, the influ-
ence of within-city exposure contrasts was estimated in the
final model controlled for sonographer. Differential suscep-
tibility was investigated by stratifying for age categories,
gender, ethnicity, diabetes mellitus status, hypertension
categories (using the criteria of the Seventh Report of the
Joint National Committee on Prevention, Detection, Evalua-
tion, and Treatment of High Blood Pressure, as derived from
the blood pressure variables from examination 1) (20), antihy-
pertensive use, obesity (obese if body mass index [BMI] 30
g/m2), smoking status, and residential stability (people who
ived in the same address for5 versus5 years’ duration). In
ddition, we tested for interaction for age, BMI, SBP, and
iastolic blood pressure as continuous variables.
The effect of lipid-lowering medications and the antihy-
ertensive medications classified as angiotensin-converting
nzyme (ACE) inhibitors, angiotensin receptor blockers,
eta-blockers, calcium channel blockers, diuretics, and va-
odilators was investigated. Analysis was conducted by using
tratification and by evaluating effect modification through
nteraction terms for the respective categories.
esults
haracteristics of the study population. Of the 6,814
ESA participants, only a subset of images from the
rachial ultrasound examinations was analyzed due to qual-
ty control and funding reasons and also only in 5 of the 6
ESA study sites. Similar to the main cohort, our study
opulation of 3,040 subjects included 50% female patients
nd 18% with less than a high school education. The
xclusion of 1 site resulted in a lower proportion of African
mericans and higher proportion of Chinese Americans
han in the overall MESA cohort. Fifteen percent of the
tudy population used lipid-lowering drugs, and 34% were
reated for hypertension (Table 1). Approximately 21% of
he participants had moved residential location within 5
ears before their brachial examination. Estimated long-
erm PM2.5 concentrations ranged from 10.6 to 24.7 g/m
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November 20/27, 2012:2158–66 Endothelial Dysfunction and Air Pollutionwith an IQR of 3 g/m3. Short-term PM2.5 concentrations
anged from 1 to 74 g/m3, with an IQR of 12 g/m3
(Fig. 1). The mean BAD and FMD% in this cohort were
4.3  0.8 mm and 4.4  2.8%, respectively (Table 2).
Long-term exposure to PM2.5 and its association with
reduced NO-mediated endothelial function. We found a
significant inverse association between long-term PM2.5
concentrations and FMD% but not with BAD. For every
3-g/m3 increase in the annual average of PM2.5, FMD%
ecreased by 0.3% (95% CI: 0.6 to 0.03; p  0.03)
ndependent of cardiovascular risk factors (Table 3, Fig. 2).
weaker but highly statistically significant relationship was
bserved between long-term PM2.5 concentrations and
MD% (0.1% [95% CI: 0.2 to 0.04]; p  0.005)
ithout adjustment for sonographer or city (Online Table 1).
xclusion of sonographers who performed 1 to 2 examinations
id not affect these estimates. Restricting analysis to those
Demographic and Health Characteristics of theMESA Parti ipants During Examination 1 (2000Table 1 Demographic and Heal h Charact rMESA Participants During Examina
Characteristic
All Par
(N 
Age (yrs) 62.2
Systolic blood pressure (mm Hg) 126.6
Diastolic blood pressure (mm Hg) 72.0
Body mass index (kg/m2) 28.3
Body surface area (m2) 1.85
Blood glucose (mg/dl)* 97.5
High-density lipoprotein (mg/dl)* 50.9
Total cholesterol (mg/dl)* 194.2
C-reactive protein (mg/l)* 3.8
Physical activity (MET min/week) 807.3
Less than high school education 1,225
Current alcohol users 3,749
Gender
Men 3,601
Women 3,213
Ethnicity
White 2,622
Chinese American 803
African American 1,893
Hispanic 1,496
Smoking status*
Never 3,418
Former 2,487
Current 887
Diabetes mellitus status (ADA 2003 criteria)*
Normal 5,087
Impaired fasting glucose 844
Nontreated DM 179
Treated DM 680
Drug use
Antihypertensive medications* 2,536
Lipid-lowering drugs* 1,100
Values are mean  SD or n (%), and p values were obtained from
Atherosclerosis (MESA) participants and those with complete data. *Ind
less due to missing information.
ADA  American Diabetes Association; DM  diabetes mellitus; Mith a stable residential address for 5 years did not affecthe association (Online Table 2). In sensitivity analyses
sing the FMD% without adjustment for 1/BAD (0.3%
95% CI: 0.5 to 0.01]; p  0.06) or the simple FMDmm
0.01 mm [95% CI: 0.02 to 0.001]; p  0.07), this
egative association persisted.
Short-term PM2.5 concentrations were associated with a
small but not statistically significant reduction in FMD%
(0.1% [95% CI:0.2 to 0.04]; p 0.4) and BAD (0.01
mm [95% CI: 0.05 to 0.01]; p  0.4) for the day 1 before
examination when adjusted for risk factors, seasonality, and
meteorology (Table 4). Associations with long-term PM2.5
exposure did not significantly change when short-term
exposure estimates or temperature or season were included
in the model (Online Table 3).
City-specific differences for vascular outcomes and PM2.5
association. Models stratified according to city demon-
strated that the relationship between long-term PM2.5
02)of the
(2000–2002)
ts
)
Participants With Complete Data
(n  3,040) p Value
61.2 9.9 0.001
125.5 19.7 0.001
72.2 10.3 0.45
27.7 5.1 0.01
1.86 2.3 0.001
96.2 28.1 0.05
50.6 14.6 0.3
194.4 34.9 0.6
3.4 5.4 0.002
.3 821.3 842.3 0.4
) 559 (18.4) 0.4
) 1,681 (55.3) 0.001
) 1,545 (50.8) 0.06
) 1,495 (49.2)
) 1,023 (33.9) 0.001
) 605 (19.8)
) 641 (21.1)
) 765 (25.1)
) 1,654 (54.4) 0.001
) 1,033 (33.9)
) 355 (11.6)
) 2,340 (76.9)
) 369 (12.1) 0.1
71 (2.3)
) 260 (8.5)
) 1,042 (34.3) 0.01
) 465 (15.3) 0.3
t or chi-square test for difference between all Multi-Ethnic Study of
the covariates for which the total number of available participants was
etabolic equivalent.–20istics
tion 1
ticipan
6,814
 10.2
 21.5
 10.0
 5.5
 2.3
 30.2
 14.8
 35.7
 5.9
 793
(18.0
(55.4
(52.9
(47.2
(38.5
(11.8
(27.8
(21.9
(50.3
(36.6
(13.1
(74.9
(12.4
(2.6)
(10.0
(37.2
(16.1
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Endothelial Dysfunction and Air Pollution November 20/27, 2012:2158–66tive across the 5 communities, except for St. Paul, which
had the lowest mean PM2.5 concentrations. Chicago par-
ticipants showed the largest decrease in FMD% per IQR
increase in PM2.5 (Table 3). Similar effect estimates were
noted when sonographer was not included as a covariate.
Assessing effect modification of association between
long-term PM2.5 exposure and NO-mediated endothelial
dysfunction. A significant interaction was found between
age and the association between long-term PM2.5 and the
Figure 1 Distribution of the PM2.5 Concentrations
(A) Long-term particulate matter 2.5 m in aerodynamic diameter (PM2.5)
concentrations estimated for the year 2000 annual average. (B) Short-term
PM2.5 concentrations for 2 days before the brachial examination. Similar
distribution pattern was seen for all other averaging time points.
Distribution of Brachial Artery Outcomes and Sonographers AmongIncluded in the Final Study Model (N  3,040)Table 2 Dist ibution of Brachial Artery Outcomes and SonograpIncluded in the Final Study Model (N  3,040)
Outcome
Chicago
(n  681)
Los Angeles
(n  800)
Baseline arterial diameter (mm) 4.2 0.8 4.4 0.8
Flow-mediated dilation (mm) 0.2 0.1 0.2 0.1
Flow-mediated dilation (%) 4.8 2.9 4.2 2.5
No. of sonographers 9 5Abbreviation as in Table 1.MD% (p  0.001) but not for BMI or blood pressure.
ounger age was associated with a larger magnitude of effect
f PM2.5 on reduced endothelial function (FMD% 0.5%
95% CI: 0.8 to 0.2%]; p  0.001). Stratified analyses
uggest that women, never smokers, participants with stages
and 2 hypertension, and those not taking antihypertensive
edications tend to have a slightly greater negative associ-
tion of PM2.5 with FMD% (Online Table 3). Although no
ategory of medication usage demonstrated statistically
ignificant effect modification, the association between
ong-term PM2.5 and FMD% seemed to be ameliorated by
CE inhibitor use (n  163); there was a 0.3% increase
95% CI: 1.04 to 1.6) in FMD% per 3-g/m3 annual
increase in PM2.5 (Online Table 4).
Discussion
In this large, multisite, multiethnic cohort, a significant
association was observed between long-term residential
PM2.5 concentrations and NO-mediated endothelial dys-
function as assessed by FMD, independent of major car-
diovascular risk factors. Although previous studies (5,6,21)
have assessed the relation between short-term exposure to
PM2.5 and endothelial function, this is the first investigation
of the relation between long-term PM2.5 exposure and
endothelial function. Our study provides unique insights
into the mechanisms of long-term PM2.5 exposure and
ncreased cardiovascular mortality.
Increasing age, SBP, BMI, and smoking are inversely
elated to FMD (19). The magnitude of the long-term
ffect of an IQR (difference between the 25th and 75th
ercentile) increase in PM2.5 on FMD% is comparable to
the effect of 5 years’ increase in age, or of active tobacco
smoking, in this population. A 3-g/m3 increase in PM2.5
concentration occurs as a contrast in residential exposure
between less polluted and more polluted areas in most major
U.S. metropolitan areas. Taken together, these data suggest
that PM2.5 exerts a clinically relevant degree of effect on
ndothelial dysfunction.
Endothelial dysfunction measured by using FMD is a
recursor for atherogenesis (22) and is associated with
ypertension (23), passive smoking (24), and cardiovascular
vents (11,25). Although the role of FMD as a predictor is
till controversial, it is consistently associated with future
ardiovascular events (26). In a nested case-cohort study
sing MESA data, abnormal FMD was predictive of
MESA ParticipantsAmong the MESA Participants
ew York
n  584)
St. Paul
(n  473)
Winston-Salem
(n  502)
Total
(N  3,040)
4.4 0.8 4.3 0.9 4.3 0.9 4.3 0.8
0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.1
4.2 2.6 5.0 3.2 4.0 2.9 4.4 2.8
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November 20/27, 2012:2158–66 Endothelial Dysfunction and Air Pollutionincident cardiovascular events independent of other ma-
jor cardiovascular risk factors (11). Furthermore, a recent
meta-analysis using pooled data from 14 studies (includ-
ing 5,447 participants) found that a 1% decrease in
FMD% was associated with an 8% increase in cardiovas-
cular mortality independent of risk factors (26). In our
study, a 10 g/m3 annual increase in PM2.5 concentration
Associations Between Brachial Artery Outcomes and the Long-TermTable 3 Associations Between Brachial Artery Outcomes and t
Final Model
BAD (mm)
-Coefficient (95% CI)
Total population (n  3,040) 0.002 (0.06 to 0.06)
Chicago (n  681) 0.1 (0.3 to 0.002)
Los Angeles (n  800) 0.1 (0.02 to 0.2)
New York (n  584) 0.2 (0.4 to0.02)
St. Paul (n  473) 0.02 (0.4 to 0.5)
Winston-Salem (n  502) 0.2 (0.1 to 0.5)
All associations reported for baseline arterial diameter (BAD) as millimeters and for flow-media
erodynamic diameter (PM2.5) for the long-term exposure. Effect estimates (-coefficients) and
odeling. Final model includes age, gender, body surface area, sonographer, income, education, sm
iastolic blood pressure, total cholesterol, high-density lipoprotein, C-reactive protein, fibrinogen,
rugs, and ascorbate (also 1/BAD for FMD). p Values are based on the final model of the multipl
nalysis. Interaction testing did not reveal any significant effect modification for the city-specific a
Figure 2 Dose-Response Associations Between Brachial Outco
Modeled Long-Term Pollutant Concentrations After Co
The values for (A) baseline arterial diameter (BAD) and (B) flow-mediated dilation
ity, body surface area, sonographer, income, education, smoking, alcohol use, die
pressure, diastolic blood pressure, total cholesterol, high-density lipoprotein, C-rea
agents, antihypertensive agents, lipid-lowering drugs, and vitamin C. FMD% include
with smoothness parameter selected by generalized cross-validation for BAD andwas associated with a 1% decrease in FMD% (regardless
of the adjustment for 1/BAD). Although we report our
outcomes for an IQR increase in the PM2.5 contrast, the
equivalent of a 10-g/m3 exposure contrast has previ-
usly been associated with a 9% increase in cardiopulmo-
ary mortality in the American Cancer Society Cancer
revention Study II (27) and a 24% increase in cardio-
osures to PM2.5ng-Term Exposures to PM2.5
FMD (%)
p Value -Coefficient (95% CI) p Value
1.0 0.3 (0.6 to0.03) 0.03
0.05 0.6 (1.1 to 0.01) 0.05
0.13 0.2 (0.6 to 0.2) 0.3
0.03 0.3 (1.1 to 0.4) 0.4
0.9 0.2 (1.9 to 2.4) 0.8
0.2 0.1 (1.5 to 1.3) 0.9
tion (FMD) as percentage per interquartile range of 3 g/m3 in particulate matter 2.5 m in
onfidence intervals (CIs) are shown for these associations derived from the multiple regression
, alcohol use, dietary fat intake, emotional distress, physical activity, waist to hip ratio, systolic and
ysteine, fasting blood glucose, anti-inflammatory agents, antihypertensive agents, lipid-lowering
ssion analysis controlled for all the these covariates for the total population and the city-specific
.
and
ling for Covariates
represent partial residuals from a final model controlled for age, gender, ethnic-
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vational Study (28).
Our finding regarding short-term exposures, although
not statistically significant, is still notable given the prior
association with endothelial dysfunction in both experimen-
tal (8,9) and observational (5,21) studies. Our results of
larger associations with long-term compared with short-
term associations (one-tenth of the effect estimate for
short-term compared with long-term) parallel the larger
magnitude of effect on cardiovascular mortality noted in
previous population-based studies (27–29). For example, a
10-g/m3 increase in short-term exposure to particulate
matter is typically associated with a 0.1% to 0.5% mortality
increase in the large multicity studies (30) compared with
10% or greater mortality increases in long-term exposure
cohort studies (1,27,28). The lack of more robust findings
for short-term analysis may be due to limited statistical
power or the simplified approach to short-term exposure
estimation compared with long-term exposures.
Several mechanisms have been proposed to explain the
potential cardiovascular risk associated with pollutants, in-
volving oxidative stress, inflammation, and autonomic im-
balance, each of which can affect the endothelium directly or
indirectly. A recent study found an association between
arterial stiffness and annual average concentrations of nitro-
gen dioxide and sulfur dioxide but not PM2.5 (31). Reduced
production and efficacy of NO in the vasculature is a
hallmark of endothelial dysfunction. Previous studies in
humans (8,9) have shown vasoconstriction and altered
FMD with PM2.5 but typically on an acute time scale.
Stimulation of the angiotensin-1 receptor (32) or uncou-
pling of endothelial NO synthase (33) or generation of
highly reactive oxygen species via nicotinamide adenine
dinucleotide phosphate (reduced) oxidase and Toll-like
receptor pathways (34) and Rho kinase activation (35) have
been proposed as the relevant vascular mechanisms of
PM2.5. We found that long-term exposure to PM2.5 might
roduce chronic changes in the brachial artery that nega-
ively affects its ability to react to shear stress, primarily from
Associations Between Short-Term PM2.5 Concenand the Brachial Artery OutcomesTable 4 Associations Between Short-Term Pand the Brachial Artery Outcomes
Outcome
BAD (m
-Coefficient (95%
Day 0 (n  2,695) 0.02 (0.06 to 0.
Day 1 (n  2,715) 0.01 (0.05 to 0.
Day 2 (n  2,709) 0.001 (0.04 to 0.
Average of 3 days (n  2,550) 0.02 (0.06 to 0.
All associations reported for BAD as millimeters and for FMD as p
concentrations derived from central-site monitors on days 0, 1, and 2,
Effect estimates (-coefficients) and 95% CIs are shown for these asso
age, gender, body surface area, sonographer, income, education, smok
to hip ratio, systolic and diastolic blood pressure, total cholesterol, h
blood glucose, anti-inflammatory agents, antihypertensive agents, lipi
included interaction for each city and day of the week as well as B-spl
and humidity (6 df/year) for these short-term exposures.
Abbreviations as in Table 3.O-mediated endothelial dysfunction. eInsights into potential mechanisms of PM2.5 exposure on
endothelial function are further suggested by a subgroup
analysis analyzing antihypertensive medication use. Al-
though limited by subgroup sizes, we found that the use of
ACE inhibitors, but not other classes of antihypertensive
agents (including angiotensin receptor blockers) or lipid-
lowering drugs, seemed to abrogate the association between
long-term PM2.5 concentrations and FMD%. Elevated
endothelial kinins and NO from ACE inhibition could play
a role in mitigating PM2.5-induced endothelial dysfunction
36,37). Recently, we found that the genetic variation in the
enin-angiotensin-aldosterone pathway seemed to modify
he effect of traffic-related air pollution on increased left
entricular mass in the MESA cohort (38).
tudy strengths and limitations. Major strengths of our
tudy include availability of vascular functional measure-
ents in a large multiethnic cohort with high-quality
ontrol standards and excellent data on covariates. We took
dvantage of the specialized monitoring and sophisticated
xposure models from MESA Air to predict spatially
esolved, individual-specific estimates at each participant’s
ome (15).
Our study has several limitations. Most importantly, this
s a cross-sectional evaluation of images collected on 1
ccasion; important information might be gained by a
ongitudinal study of vascular function. Our findings also
ay not be generalizable to either normal younger individ-
als or those with recognized clinical disease. It should be
oted that although our long-term exposure estimates are
erived from sophisticated exposure modeling methods,
hey are subject to measurement error and may not fully
eflect an individual’s long-term exposure because informa-
ion on specific microenvironments, time-activity patterns,
r periods of exposure 1 year before testing is lacking.
uture MESA Air exposure metrics will be able to incor-
orate individual-level data on pollutant infiltration effi-
iencies and time spent indoors, which will improve these
stimates.
FMD is a commonly applied marker for NO-mediated
onsConcentrations
FMD (%)
p Value -Coefficient (95% CI) p Value
0.1 0.06 (0.2 to 0.08) 0.4
0.4 0.10 (0.2 to 0.04) 0.2
0.9 0.08 (0.2 to 0.05) 0.2
0.3 0.1 (0.3 to 0.05) 0.3
ge for a daily interquartile range increase of 12 g/m3 of PM2.5
average of these 3 days, before the brachial ultrasound examination.
s derived from the multiple regression modeling. Final model includes
ohol use, dietary fat intake, emotional distress, physical activity, waist
sity lipoprotein, C-reactive protein, fibrinogen, homocysteine, fasting
ing drugs, and ascorbate (also 1/BAD for FMD%). In addition, we also
temporal variables temperature (4 df/year), seasonality (12 df/year),tratiM2.5
m)
CI)
01)
01)
04)
02)
ercenta
and the
ciation
ing, alc
igh-den
d-lower
ines ofndothelial dysfunction (39). We found consistent associa-
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dysfunction, whether expressed as FMD% (with or without
adjustment for 1/BAD) or the simple change in FMDmm.
Because MESA did not include nitroglycerin administra-
tion, we could not rule out NO-independent endothelial
dysfunction in this analysis.
Conclusions
This is the first epidemiological study to suggest that
long-term exposure to PM2.5 is associated with decreased
endothelial function in a conduit artery independent of
cardiovascular risk factors. This finding provides a clue that
long-term perturbations of the endothelium–smooth muscle
complex from PM2.5 exposure lead to chronic functional
hanges. These functional changes may partly explain the
isk of cardiovascular events previously associated with these
nvironmental exposures.
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